GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nath Bio-Genes (I) NATHBIOGEN.NS · INR

Consumer Staples · NSE · 🇮🇳 India

Compare

139.65

+1.62%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹4.45bn

FY2017FY2026

Net income

₹416.3m

FY2017FY2026

Free cash flow

−₹250.4m

FY2017FY2026

Shareholders' equity

₹6.80bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹4.45bn₹3.65bn₹2.48bn₹3.01bn₹2.78bn₹3.07bn₹2.80bn₹2.31bn₹1.92bn₹1.70bn
Research and development₹140.8m₹124.2m₹112.8m₹93.7m₹88.9m₹91.5m₹91.0m₹25.7m₹78.8m₹86.7m
Operating income₹484.7m₹459.8m₹477.0m₹464.4m₹1.38bn₹652.3m₹533.7m₹419.9m₹415.0m₹361.6m
Net income₹416.3m₹386.0m₹396.2m₹350.1m−₹673.4m₹556.6m₹504.8m₹384.3m₹294.2m₹162.8m
Diluted earnings per share21.9120.3119.8818.42-35.4329.3426.5120.1815.4810.19

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹10.97bn₹10.26bn₹8.80bn₹7.93bn₹7.42bn₹7.90bn₹7.30bn₹6.46bn₹5.71bn₹2.89bn
Cash and short-term investments₹760.0m₹889.0m₹774.1m₹379.9m₹41.7m₹292.1m₹219.8m₹213.8m₹446.6m₹58.5m
Total liabilities₹4.17bn₹3.82bn₹2.70bn₹2.20bn₹2.00bn₹1.76bn₹1.72bn₹1.38bn₹1.02bn₹1.52bn
Debt₹1.39bn₹1.23bn₹1.10bn₹1.05bn₹929.6m₹965.7m₹701.5m₹581.5m₹325.8m₹686.8m
Shareholders' equity₹6.80bn₹6.44bn₹6.10bn₹5.73bn₹5.42bn₹6.13bn₹5.58bn₹5.08bn₹4.69bn₹1.38bn
Shares outstanding19m19m20m19m19m19m19m19m19m16m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−₹220.4m₹175.8m₹614.8m₹383.7m₹170.5m₹11.1m₹94.7m−₹219.9m−₹469.8m₹33.4m
Capital spending−₹30.1m−₹79.2m−₹83.9m−₹25.5m−₹210.2m−₹116.0m−₹162.0m−₹223.0m−₹48.6m−₹41.3m
Free cash flow−₹250.4m₹96.6m₹530.9m₹358.2m−₹39.7m−₹104.9m−₹67.3m−₹442.8m−₹518.4m−₹7.8m
Dividends paid−₹38.0m−₹38.0m−₹38.0m−₹38.0m−₹38.0m−₹38.0m−₹38.0m−₹38.0m——

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹3.28bn₹515.9m₹659.6m₹438.5m₹2.84bn₹519.7m₹368.7m₹321.9m
Operating income₹341.5m₹34.5m₹26.0m₹87.7m₹373.1m₹29.3m₹72.1m₹39.9m
Net income₹322.6m−₹89,000₹16.0m₹48.2m₹372.8m₹14.8m₹26.5m₹11.1m
Diluted earnings per share16.98-0.000.842.5319.620.781.330.56
Cash from operations———−₹1.09bn—₹175.0m—−₹837.0m
Capital spending———−₹11.0m—−₹79.0m—−₹32.0m
Free cash flow———−₹1.10bn—₹96.0m—−₹869.0m
Total assets—₹10.97bn—₹10.14bn—₹10.26bn—₹8.28bn
Cash and short-term investments₹760.0m₹760.0m₹7.4m₹1.59bn₹889.0m₹889.0m₹20.8m₹20.8m
Debt—₹1.39bn—₹1.55bn—₹1.23bn—₹1.27bn
Shareholders' equity₹6.80bn₹6.80bn₹6.80bn₹6.80bn₹6.44bn₹6.44bn₹6.40bn₹6.40bn

Financial ratios

Data as of 25 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Operating margin14.0%12.6%20.4%15.2%-19.0%21.3%
Net margin9.4%10.6%16.0%11.6%-24.2%18.1%
Return on equity6.1%6.0%6.5%6.1%-12.4%9.1%
Return on assets3.8%3.8%4.5%4.4%-9.1%7.1%
Free cash flow yield-8.9%7.1%23.6%15.5%6.9%0.4%
Revenue growth22.0%47.4%-17.8%8.2%-9.4%9.8%
Earnings growth7.9%-2.6%13.2%-152.0%-221.0%10.3%
Current ratio1.97x1.89x2.18x2.41x2.41x3.03x
Debt to equity0.20x0.19x0.18x0.18x0.17x0.16x
Equity ratio62.0%62.8%69.3%72.3%73.1%77.7%
Interest coverage3.90x4.39x5.72x4.49x-4.96x7.40x
R&D as a share of sales3.2%3.4%4.6%3.1%3.2%3.0%
Buybacks as a share of market value0.0%4.6%-4.9%0.0%-0.2%0.4%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue13.9%7.7%10.6%
Operating income1.4%-5.8%8.5%
Net income5.9%-5.6%11.4%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin11.7%13.9%20.1%19.7%
Net margin9.9%11.4%7.4%9.8%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings6.27.79.411.3-4.69.010.317.127.145.5
Price to sales0.60.81.51.31.11.61.92.94.24.4

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 14 Aug 2025.

FY2026FY2025FY2024FY2023FY2022
Paid in the year2.002.004.002.002.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.